New registry study to track real-world results of post-surgery treatment for salivary gland cancer

NCT ID NCT06464198

Recruiting now Knowledge-focused Sponsor: University of Erlangen-Nürnberg Medical School Source: ClinicalTrials.gov ↗

First seen Mar 14, 2026 · Last updated May 24, 2026 · Updated 11 times

Summary

This study is creating a database of 100 people with advanced salivary gland cancer who receive standard radiation and chemotherapy together after surgery. Researchers will track survival, cancer return, and side effects to learn how well this treatment works in real-world settings. Participants must have high-grade cancer that was fully removed but still carries a high risk of coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SALIVARY GLAND CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Erlangen, Universitätsklinikum Strahlenklinik
RECRUITING

Erlangen, 91054, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LOCALLY ADVANCED SALIVARY GLAND CARCINOMA